Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.48 |
| ▸ | CA2 | P00918 | 3/20 | 0.48 |
| ▸ | CA7 | P43166 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29433653 | 1.00 | CA1 (0.48) | CA1CA2CA7CA9CA12 | |
| SCHEMBL8164294 | 0.98 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| Hydrochloric Acid SCHEMBL2827782 | 0.96 | CA1 (0.44) | CA1CA2CA7CA9CA12 | |
| SCHEMBL9854809 | 0.94 | CA1 (0.46) | CA1CA2CA7CA9CA12 | |
| SCHEMBL2827783 | 0.93 | CA1 (0.41) | CA1CA2CA7CA9CA12 | |
| SCHEMBL3799373 | 0.91 | CA1 (0.52) | CA1CA2CA7CA9CA12 | |
| SCHEMBL9721753 | 0.91 | CA1 (0.40) | CA1CA2CA7CA9CA12 | |
| SCHEMBL17529827 | 0.90 | CA1 (0.43) | CA1CA2CA7CA9CA12 | |
| SCHEMBL17529822 | 0.89 | ALOX5 (0.42) | CA1CA2CA7CA9CA12 | |
| SCHEMBL9322529 | 0.89 | CA1 (0.41) | CA1CA2CA7CA9CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 677 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3694864-B1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | QPEX BIOPHARMA INC (US) | 2025-03-05 | — | — | EP | claimed |
| CN-117186387-A | Solution polymerization method for synthesizing high molecular weight polyketone | 浙江大学衢州研究院 | 2023-12-08 | — | — | CN | claimed |
| CN-111690128-B | Preparation method of compound catalyst and polyketone | 黄河三角洲京博化工研究院有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-110669071-B | Synthetic method of polyketone ligand 1, 3-bis [ bis (2-methoxyphenyl) phosphino ] propane | 黄河三角洲京博化工研究院有限公司 | 2022-03-29 | — | — | CN | claimed |
| US-11286270-B2 | Boronic acid derivatives and synthesis thereof | QPEX BIOPHARMA, INC. (US) | 2022-03-29 | — | — | US | claimed |
| EP-2981560-B1 | CURING OF LIQUID THERMOSETTING RESINS | REICHHOLD LLC 2 (US) | 2021-10-13 | — | — | EP | claimed |
| US-20200407373-A1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | QPEX BIOPHARMA, INC. | 2020-12-31 | — | — | US | claimed |
| CN-111690128-A | Preparation method of compound catalyst and polyketone | 黄河三角洲京博化工研究院有限公司 | 2020-09-22 | — | — | CN | claimed |
| EP-3694864-A1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | Qpex Biopharma, Inc. (US) | 2020-08-19 | — | — | EP | claimed |
| CN-110669071-A | Synthetic method of polyketone ligand 1, 3-bis [ bis (2-methoxyphenyl) phosphino ] propane | 黄河三角洲京博化工研究院有限公司 | 2020-01-10 | — | — | CN | claimed |
| US-4900789-A | Polymer blend of carbon monoxide/olefin copolymer and conjugated alkadiene | SHELL OIL COMPANY (US) | 1990-02-13 | — | — | US | claimed |
| EP-0337521-A1 | Polymers of carbon monoxide with ethene | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-10-18 | — | — | EP | claimed |
| US-4870133-A | Polymer blend of polyketone polymers with tetrafluoroethylene | SHELL OIL COMPANY (US) | 1989-09-26 | — | — | US | claimed |
| US-4855400-A | Removal of catalyst residues from carbon monoxide/olefin polymers with catalyst complexing agent | SHELL OIL COMPANY (US) | 1989-08-08 | — | — | US | claimed |
| US-4855401-A | Removal of catalyst remnants from carbon monoxide/olefin polymers at temperatures higher than polymerization temperatures | SHELL OIL COMPANY (US) | 1989-08-08 | — | — | US | claimed |
| EP-0322018-A2 | Polyketone polymer preparation | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-06-28 | — | — | EP | claimed |
| EP-0319083-A2 | Polyketone polymer preparation | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1989-06-07 | — | — | EP | claimed |
| EP-0285218-A2 | Removal of catalyst remnants from olefin/CO copolymers | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-10-05 | — | — | EP | claimed |
| EP-0263564-A1 | Catalyst compositions and olefin/CO-copolymerization process | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-04-13 | — | — | EP | claimed |
| EP-0257663-A2 | Catalyst compositions, olefin/co copolymerization process and bisphosphine compounds | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-03-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200407373-A1 | BORONIC ACID DERIVATIVES AND SYNTHESIS THEREOF | BTD, BLVRB, BLK | CA1 1169/4885CA2 425/4885CA7 89/4885 |
| US-11286270-B2 | Boronic acid derivatives and synthesis thereof | BTD, BLVRB, BLK | CA1 1169/4885CA2 425/4885CA7 89/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.